California Pharmacist - Summer 2012 - (Page 29)
easily evaluate medication and test requests to determine applicability. Institutions without a comprehensive EMR may encounter barriers to the full integration of genetic test results and their application.
Legal Issues or Regulatory Requirements
Currently, informed consent is not required for pharmacogenomics testing. The tests are treated as a laboratory parameter and handled with the same procedures to ensure privacy. All counseling and risk/beneﬁ t discussions related to the genetic testing are the responsibility of the patient’s provider.
Business Case (payment for services, who pays, coding for services, etc.)
Currently, all pharmacogenomics testing is under the laboratory budget for the health system. No third party payers have been billed for service.
09/03/12 3:24 PM
Future Plans and Direction
PTEC will continue adding new tests and guidelines for their use. They plan to educate providers about “personalized medicine” and the proper use of pharmacogenomic tests. They are interested in expanding the current service to include face-to-face consults in which pharmacogenomics counseling would occur for all patients. They are also evaluating a centralized pharmacogenomics consult service with other VA Health Systems in the region. The ultimate goal is to develop standard- 556133_Guaranteed.indd ized criteria that would train all VA pharmacists to process pharmacogenomic test requests nationally. About the Authors Dr. Margaret Mendes, PharmD, is a VA San Diego Healthcare System formulary management, biologics and pharmacogenomics clinical specialist. Nathan Painter, PharmD, CDE is a health sciences clinical assistant professor at University of California, San Diego.
The One Returns Program That Started It All
Local Representative Available For Reverse Pharmaceutical On-Site Service
• • • • Processing Over 1,000 Crediting Pharmaceutical & OTC Manufacturers For Maximum Credit Free Shipping Inbound & Outbound & Disposal Of All Non-Returnables* Free Returns Monitoring With The GR-XtraNET™ No Invoicing, Fee Deducted From Actual Credits Received
Some Restrictions May Apply
Contact Fredy Kadva, Western Regional Sales Manager 1.800.473.2138 Ext.155 • email@example.com
100 Colin Drive, Holbrook, NY 11741 • www.guaranteedreturns.com
10/12/11 10:01:23 AM
www.cpha.com | SUMMER 2012 | CALIFORNIA PHARMACIST 9/30/11
Table of Contents for the Digital Edition of California Pharmacist - Summer 2012
From the Editor
From the President
Pharmacogenomics, Diagnostics & Evaluation – the Pharmacist’s Role
Overview Update of Pharmacogenomics and Disease Genetic Testing
Pharmacogenomic Testing Technology in Currently Available Test Kits
Pharmacogenomic Testing in an HIV Clinic
Pharmacogenomic Testing at the VA San Diego Healthcare System
Pharmacists and Pharmacogenomics: An evaluation of knowledge, beliefs, attitudes and practices
Pharmacy Quality Commitment helps Pharmacists Meet the Demands of Continuous Quality Improvement
Brilinta® Ticagrelor: Another Option in Antiplatelet Therapy
A Summer Half-Helix Sale
Index to Advertisers
California Pharmacist - Summer 2012
If you would like to try to load the digital publication without using Flash Player detection, please click here.